Antibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MAB8751 - Provider product page
- Provider
- R&D Systems
- Product name
- Anti-Human IGFBP-5 Monoclonal Antibody (Clone 145619)
- Antibody type
- Monoclonal
- Antigen
- Mouse myeloma cell line NS0-derived recombinant human IGFBP-5, Glu28-Glu272
- Description
- Protein A or G purified from hybridoma culture supernatant
- Reactivity
- Human
- Host
- Mouse
- Antigen sequence
P24593
- Isotype
- IgG
- Vial size
- 500 µg
Submitted references Deregulation of IGF-binding proteins -2 and -5 contributes to the development of endocrine resistant breast cancer in vitro.
Insulin-like growth factor binding protein-5 (IGFBP-5) suppresses the tumourigenesis of head and neck squamous cell carcinoma.
Hawsawi Y, Humphries MP, Wright A, Berwick A, Shires M, Al-Kharobi H, El-Gendy R, Jove M, Twelves C, Speirs V, Beattie J
Oncotarget 2016 May 31;7(22):32129-43
Oncotarget 2016 May 31;7(22):32129-43
Insulin-like growth factor binding protein-5 (IGFBP-5) suppresses the tumourigenesis of head and neck squamous cell carcinoma.
Hung PS, Kao SY, Shih YH, Chiou SH, Liu CJ, Chang KW, Lin SC
The Journal of pathology 2008 Feb;214(3):368-76
The Journal of pathology 2008 Feb;214(3):368-76
No comments: Submit comment
No validations: Submit validation data